ClinicalTrials.Veeva

Menu

Evaluation of Commercially Available Heel Pads for the Prevention of Pressure Ulcers: An Observational Study of Incidence and Usability in Adult Surgical Patients.

T

Trulife

Status

Invitation-only

Conditions

Pressure Injury Prevention

Treatments

Device: Oasis Elite Heel Pad (EL130)

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT07852897
TruE130

Details and patient eligibility

About

This study will evaluate the incidence of heel pressure ulcers in adult patients undergoing elective surgery while using the Oasis Elite Heel Pad (EL130) as part of routine pressure ulcer prevention. The study will also explore the usability, acceptability, and perceived value of the heel pad among multidisciplinary surgical theatre staff.

The study has two phases. Phase 1 is a prospective observational study involving approximately 35 adult surgical patients. The use of the heel pad is part of standard care and participation in the study will not alter participants' routine clinical care. Pressure ulcer development at both heels will be assessed using visual skin assessment (VSA) and subepidermal moisture (SEM) assessment with the Provizio® SEM Scanner. Assessments will be performed before surgery, hourly during surgery, and during postoperative follow-up for up to 72 hours.

The primary outcome of Phase 1 is the incidence of heel pressure ulcers detected by SEM assessment and VSA. The study will also examine changes in SEM measurements during surgery and the time to development of a heel pressure ulcer during the study follow-up period.

Phase 2 is a qualitative usability study involving approximately 15 multidisciplinary surgical theatre staff who have used the heel pads during the Phase 1 study period. Participants will take part in individual semi-structured interviews exploring the usability, acceptability, and perceived value of the heel pads for intraoperative pressure ulcer prevention.

Full description

Pressure ulcers are areas of tissue damage associated with pressure and shear forces and are an important potential complication for patients undergoing surgery. Patients undergoing surgical procedures may be at increased risk because they can remain immobile in one position for prolonged periods and are unable to respond to discomfort associated with pressure and shear while undergoing surgery.

The aim of this study is to determine the incidence of pressure ulcers at the heels among adult surgical inpatients using the Oasis Elite Heel Pad (EL130), with pressure ulcer development assessed using both subepidermal moisture (SEM) assessment and visual skin assessment (VSA). The study will also explore the usability, acceptability, and perceived value of the heel pad among multidisciplinary surgical theatre staff.

This is a single-site, multiphase study consisting of two phases.

Phase 1: Prospective observational study

Approximately 35 adult patients admitted for elective surgery will participate in Phase 1. Eligible participants will be adults aged 18 years or older who are admitted preoperatively for elective surgery, have a planned surgery duration of at least one hour, have an anticipated length of hospital stay of approximately three days, and are planned to use the Oasis Elite Heel Pads (EL130) as part of routine intraoperative pressure ulcer prevention.

The study does not require a change to standard clinical care. The Oasis Elite Heel Pads are already used at the study site for routine pressure ulcer prevention. Research assessments conducted during the study are additional to routine clinical assessments and do not direct or influence clinical care decisions.

Participants will undergo assessment of both heels using VSA and SEM assessment with the Provizio® SEM Scanner. A baseline assessment will be performed before surgery. Assessments will then be performed hourly during the intraoperative period and during postoperative follow-up for up to 72 hours.

VSA will assess the appearance of the skin at each heel and pressure ulcers will be classified using the NPUAP/EPUAP/PPPIA pressure ulcer classification system. SEM assessment is a non-invasive assessment performed using the Provizio® SEM Scanner. The scanner measures subepidermal moisture associated with inflammatory changes in tissue. Four measurements are collected from each heel and used to generate a SEM delta value.

The primary outcome of Phase 1 is the incidence of SEM- and VSA-detected pressure ulcers at the heels among adult surgical inpatients using the heel pad. A SEM-detected pressure ulcer will be defined as two sustained elevated SEM measurements over two consecutive days at the same anatomical location, with a SEM delta value of 0.6 or greater, among participants who had a normal SEM reading preoperatively. A VSA-detected pressure ulcer will be defined according to the NPUAP/EPUAP/PPPIA pressure ulcer classification system.

Secondary outcomes include observation of hourly SEM delta values during surgery while participants are using the heel pad and the length of time to development of a pressure ulcer at the heels during the intraoperative and postoperative study period.

Relevant demographic and surgical information will also be collected to describe the study population and provide context for the study findings. This includes age, sex, skin tone, surgery type, position during surgery, time spent in surgery, and the type of heel pad used at the heels intraoperatively.

Phase 2: Qualitative usability study

Phase 2 will explore the usability, acceptability, and perceived value of the Oasis Elite Heel Pad among multidisciplinary surgical theatre staff involved in the care of participants recruited during Phase 1.

Approximately 15 multidisciplinary surgical theatre staff who have used the heel pad intraoperatively during the Phase 1 data collection period will be invited to participate. Recruitment will continue until sufficient qualitative data have been obtained.

Following informed consent, staff participants will take part in an individual semi-structured interview lasting no more than approximately 30 minutes. Interviews will explore staff perceptions of the usability, acceptability, and perceived value of the heel pad for intraoperative pressure ulcer prevention, including usability issues and contextual barriers or facilitators that may influence its adoption and continued use in clinical practice.

Interview transcripts will be analysed using thematic analysis to identify themes relating to staff experiences and perceptions of the heel pad and potential opportunities for design or workflow improvements.

The study will be conducted at Connolly Hospital Dublin. The overall study, including preparation, data collection, analysis, and write-up, is planned to be completed within approximately 12 months.

Enrollment

35 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Adult patients aged 18 years or older
  • Admitted preoperatively for elective surgery
  • Planned surgery duration of at least 1 hour
  • Anticipated/planned length of hospital stay of 3 days
  • Able to provide informed consent to participate
  • Intraoperative use of the Oasis Elite Heel Pad (EL130) planned as part of routine pressure ulcer prevention

Exclusion criteria

  • Undergoing emergency surgery
  • Planned surgical position that does not require heel pads intraoperatively (e.g., prone position)
  • Anticipated/planned length of hospital stay of less than 3 days at study enrolment
  • Visual pressure ulcers present on both heels at baseline
  • Unable to provide informed consent
  • Oasis Elite Heel Pads (EL130) not being used intraoperatively

Trial design

35 participants in 1 patient group

Adult surgical patients using Oasis Elite Heel Pads
Description:
Adult patients undergoing elective surgery who use the Oasis Elite Heel Pad (EL130) as part of routine intraoperative pressure ulcer prevention. Participants will undergo visual skin assessment (VSA) and subepidermal moisture (SEM) assessment of both heels before surgery, hourly during surgery, and during postoperative follow-up for up to 72 hours. Use of the heel pad is part of standard care at the study site and is not assigned as a research intervention.
Treatment:
Device: Oasis Elite Heel Pad (EL130)

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems